Definitions
Sorry, no definitions found. You may find more data at afinitor.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Afinitor.
Examples
-
The medicine, known generically as everolimus and usually sold under the name Afinitor, has already been approved in the U.S. for this brain tumor disease and could reach annual sales of around $300 million in this indication, Bank Vontobel analyst Andrew Weiss said.
Novartis Tumor Pill Wins European Approval Goran Mijuk 2011
-
Afinitor, which is already approved for other cancers in Europe and the U.S., works by inhibiting a protein that can trigger cancer growth.
Novartis Drug Seeks Wider Use Goran Mijuk 2011
-
The proposed brand name Afinitor, has been accepted by the European regulator and is under review in the U.S.
-
Everolimus, also known as Afinitor, has been shown to increase overall survival in cases where the other two have failed.
BBC News - Home 2011
-
In the first study, 724 postmenopausal women with hormone receptor-positive breast cancer were randomly assigned to receive the aromatase inhibitor Aromasin exemestane plus a placebo or Aromasin plus Afinitor, which is already approved for treatment of kidney cancer.
-
Approved in the US for this patient population under the trade name Afinitor ® everolimus tablets Summary of Product Characteristics.
-
Everolimus is approved under the trade name Afinitor® (everolimus) tablets for the treatment of patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib.
THE MEDICAL NEWS 2010
-
In the US, everolimus is approved under the trade name Afinitor® (everolimus) tablets for the treatment of patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib.
-
These therapies are RAD001, an mTOR inhibitor recently approved by the US Food and Drug Administration (FDA) under the brand name Afinitor® (everolimus) tablets for patients with advanced renal cell carcinoma after failure of treatment with sunitinib or sorafenib; and patupilone, a novel non-taxane microtubule stabilising agent in phase III trials for ovarian cancer and in earlier-stage trials in other settings.
-
April 2, 2009 -- The FDA has approved a new drug called Afinitor to treat advanced renal cell carcinoma after other treatments fail.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.